Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Candidemia – Market Insights, Epidemiology, and Market Forecast-2030” drug pipelines has been added to ResearchAndMarkets.com’s offering. The Candidemia…
DUBLIN–(BUSINESS WIRE)–The “Candidemia – Market Insights, Epidemiology, and Market Forecast-2030” drug pipelines has been added to ResearchAndMarkets.com’s offering. The Candidemia…
Marinus is moving towards a pre-NDA meeting, targeted for the end of Q1, in support of NDA submission by the…
Marinus is moving towards a pre-NDA meeting, targeted for the end of Q1, in support of NDA submission by the…
Marinus is moving towards a pre-NDA meeting, targeted for the end of Q1, in support of NDA submission by the…
Marinus is moving towards a pre-NDA meeting, targeted for the end of Q1, in support of NDA submission by the…
Marinus is moving towards a pre-NDA meeting, targeted for the end of Q1, in support of NDA submission by the…
24-Month Average IOP Reductions of 7.9 mmHg and 7.4 mmHg in Fast- and Slow-Release iDose TR Arms, Respectively Favorable Safety…
Initial program to focus on development of a companion diagnostic for HiberCell’s novel immunotherapy, Imprime PGG, to aid in patient…
Substantial IOP Reduction Observed with Highly Favorable Safety Profile Through 12 Months 76% of Subjects Achieved 20% or Greater Reduction…